Đang chuẩn bị liên kết để tải về tài liệu:
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
The anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (moAbs) cetuximab or panitumumab are administered to colorectal cancer (CRC) patients who harbor wild-type RAS proto-oncogenes. |